Fig. 6.

LEDGF/p75 is involved in cancer immunity. (A) Correlations between LEDGF/p75 and immune subtypes were obtained from the TSIDB database. (B) The box plot retrieved from the TISMO database shows LEDGF/p75 expression levels across cell lines between pre- and postcytokine-treated samples. (C) The table shows the correlation between LEDGF/p75 expression and CTLs, T dysfunction, and risks. The bottom graphs show detailed information on corresponding data in the table. (D-G) Box plots show differential expression of LEDGF/p75 in the indicated groups. ROC curves illustrate the feasibility of LEDGF/p75 expression as an indicator of the effectiveness of immunotherapy. * P < 0.05, * * P < 0.01, * ** P < 0.001.